Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
Hybrid molecules obtained through conjugation of monoclonal antibodies and toxins constitute an approach under exploration to generate potential agents for the treatment of cancer and other diseases. A frequently employed toxic component in the construction of such immunotoxins is ricin, a plant tox...
Guardado en:
Autores principales: | AVILA,ANA D, CALDERÓN,CARLOS F, PEREZ,RITA M, PONS,CARMEN, PEREDA,CELIA M, ORTIZ,ANA R |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2007
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602007000200008 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of molecular recognition element for the quantification of human epidermal growth factor using surface plasmon resonance
por: Rosti,Ira Amira, et al.
Publicado: (2013) -
Antibody-Based Immunotoxins for Colorectal Cancer Therapy
por: Laura Sanz, et al.
Publicado: (2021) -
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
por: Lewis J. Renshall, et al.
Publicado: (2021) -
INFLUENCE OF S. TYPHI LIPOPOLISACCHARIDE UPON EPITHELIZATION OF SKIN WOUNDS AND EPIDERMAL GROWTH FACTOR SECRETION
por: A. V. Kostarnoy, et al.
Publicado: (2014) -
Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance
por: Yukari Tsubata, et al.
Publicado: (2021)